|
US6291438B1
(en)
|
1993-02-24 |
2001-09-18 |
Jui H. Wang |
Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use
|
|
US5858988A
(en)
|
1993-02-24 |
1999-01-12 |
Wang; Jui H. |
Poly-substituted-phenyl-oligoribo nucleotides having enhanced stability and membrane permeability and methods of use
|
|
US9637739B2
(en)
|
2012-03-20 |
2017-05-02 |
Vilnius University |
RNA-directed DNA cleavage by the Cas9-crRNA complex
|
|
EP3363902B1
(en)
|
2012-12-06 |
2019-11-27 |
Sigma Aldrich Co. LLC |
Crispr-based genome modification and regulation
|
|
DK2931898T3
(en)
|
2012-12-12 |
2016-06-20 |
Massachusetts Inst Technology |
CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH FUNCTIONAL DOMAINS
|
|
CA2894684A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Engineering and optimization of improved crispr-cas systems, methods and enzyme compositions for sequence manipulation in eukaryotes
|
|
US9234213B2
(en)
|
2013-03-15 |
2016-01-12 |
System Biosciences, Llc |
Compositions and methods directed to CRISPR/Cas genomic engineering systems
|
|
WO2015066119A1
(en)
|
2013-10-30 |
2015-05-07 |
North Carolina State University |
Compositions and methods related to a type-ii crispr-cas system in lactobacillus buchneri
|
|
WO2015089364A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Crystal structure of a crispr-cas system, and uses thereof
|
|
CA2945335A1
(en)
|
2014-04-18 |
2015-10-22 |
Editas Medicine, Inc. |
Crispr-cas-related methods, compositions and components for cancer immunotherapy
|
|
CA2963820A1
(en)
|
2014-11-07 |
2016-05-12 |
Editas Medicine, Inc. |
Methods for improving crispr/cas-mediated genome-editing
|
|
EP3265559B1
(en)
|
2015-03-03 |
2021-01-06 |
The General Hospital Corporation |
Engineered crispr-cas9 nucleases with altered pam specificity
|
|
KR20260048600A
(ko)
*
|
2015-03-27 |
2026-04-10 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
변형된 t 세포 및 이의 제조 및 사용 방법
|
|
EP3294342A4
(en)
|
2015-05-08 |
2018-11-07 |
President and Fellows of Harvard College |
Universal donor stem cells and related methods
|
|
CN107849546A
(zh)
|
2015-05-15 |
2018-03-27 |
先锋国际良种公司 |
对cas内切核酸酶系统、pam序列和指导rna元件的快速表征
|
|
EP3303634B1
(en)
|
2015-06-03 |
2023-08-30 |
The Regents of The University of California |
Cas9 variants and methods of use thereof
|
|
US20160362667A1
(en)
|
2015-06-10 |
2016-12-15 |
Caribou Biosciences, Inc. |
CRISPR-Cas Compositions and Methods
|
|
WO2016205759A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
|
TWI813532B
(zh)
|
2015-06-18 |
2023-09-01 |
美商博得學院股份有限公司 |
降低脱靶效應的ｃｒｉｓｐｒ酶突變
|
|
EA201891338A1
(ru)
*
|
2015-12-04 |
2018-12-28 |
Новартис Аг |
Композиции и способы для иммуноонкологии
|
|
AU2016370726B2
(en)
|
2015-12-18 |
2022-12-08 |
Danisco Us Inc. |
Methods and compositions for polymerase II (Pol-II) based guide RNA expression
|
|
KR102438360B1
(ko)
*
|
2016-03-04 |
2022-08-31 |
에디타스 메디신, 인코포레이티드 |
암 면역요법을 위한 crispr-cpf1-관련 방법, 조성물 및 구성성분
|
|
EP3699281A1
(en)
|
2016-03-11 |
2020-08-26 |
Pioneer Hi-Bred International, Inc. |
Novel cas9 systems and methods of use
|
|
CN116850305A
(zh)
|
2016-05-06 |
2023-10-10 |
朱诺治疗学股份有限公司 |
基因工程化细胞及其制备方法
|
|
US12431216B2
(en)
|
2016-08-17 |
2025-09-30 |
Broad Institute, Inc. |
Methods for identifying class 2 crispr-cas systems
|
|
WO2018041120A1
(en)
|
2016-08-31 |
2018-03-08 |
Beijing Biocytogen Co., Ltd |
Genetically modified non-human animal with human or chimeric tigit
|
|
WO2018064594A2
(en)
*
|
2016-09-29 |
2018-04-05 |
Nantkwest, Inc. |
Hla class i-deficient nk-92 cells with decreased immunogenicity
|
|
JP7306696B2
(ja)
|
2016-09-30 |
2023-07-11 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Ｒｎａ誘導型核酸修飾酵素及びその使用方法
|
|
SG10201913505WA
(en)
|
2016-10-17 |
2020-02-27 |
Univ Nanyang Tech |
Truncated crispr-cas proteins for dna targeting
|
|
WO2018073393A2
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy
|
|
KR102528384B1
(ko)
|
2017-01-06 |
2023-05-02 |
이뮤너티바이오, 인크. |
감소된 cd96/tigit 발현을 갖는 유전자 변형된 nk-92 세포
|
|
AU2018240515B2
(en)
|
2017-03-24 |
2024-07-25 |
CureVac SE |
Nucleic acids encoding CRISPR-associated proteins and uses thereof
|
|
KR102758434B1
(ko)
|
2017-03-30 |
2025-01-21 |
고쿠리츠 다이가쿠 호진 교토 다이가쿠 |
게놈 편집에 의한 엑손 스키핑 유도 방법
|
|
MX2019013514A
(es)
|
2017-05-12 |
2020-01-20 |
Crispr Therapeutics Ag |
Materiales y metodos para modificar celulas por ingenieria genetica y usos de los mismos en inmunooncologia.
|
|
EP3625338A4
(en)
|
2017-05-19 |
2021-01-20 |
Tsinghua University |
CONSTRUCTION OF A MINIMAL SACAS9-CRISPR / CAS SYSTEM FOR GENEDITATION AND TRANSCRIPTION REGULATION, OPTIMIZED BY EXTENDED GUIDE-RNA
|
|
CN107164377A
(zh)
|
2017-06-12 |
2017-09-15 |
王小平 |
基于碱基编辑的基因敲除方法及其应用
|
|
US9982279B1
(en)
|
2017-06-23 |
2018-05-29 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
|
US10011849B1
(en)
|
2017-06-23 |
2018-07-03 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
|
CN107723275B
(zh)
*
|
2017-10-20 |
2020-09-04 |
重庆精准生物技术有限公司 |
通用型car-t细胞及其制备方法和应用
|
|
AU2018364993B2
(en)
|
2017-11-10 |
2022-10-06 |
University Of Massachusetts |
Targeted CRISPR delivery platforms
|
|
US10253365B1
(en)
|
2017-11-22 |
2019-04-09 |
The Regents Of The University Of California |
Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
|
|
WO2019118516A1
(en)
|
2017-12-11 |
2019-06-20 |
Editas Medicine, Inc. |
Cpf1-related methods and compositions for gene editing
|
|
CN111902536B
(zh)
|
2018-02-15 |
2024-07-30 |
西格马-奥尔德里奇有限责任公司 |
用于真核基因组修饰的改造的cas9系统
|
|
KR20200124702A
(ko)
|
2018-02-23 |
2020-11-03 |
파이어니어 하이 부렛드 인터내쇼날 인코포레이팃드 |
신규한 cas9 오르소로그
|
|
KR20200130826A
(ko)
|
2018-03-15 |
2020-11-20 |
케이에스큐 세러퓨틱스 인코포레이티드 |
개선된 면역요법을 위한 유전자-조절 조성물 및 방법
|
|
CA3094468A1
(en)
|
2018-04-05 |
2019-10-10 |
Juno Therapeutics, Inc. |
Methods of producing cells expressing a recombinant receptor and related compositions
|
|
AU2019252925A1
(en)
|
2018-04-13 |
2020-07-30 |
Sigma-Aldrich Co. Llc. |
Modification of immune-related genomic loci using paired CRISPR nickase ribonucleoproteins
|
|
US11396072B2
(en)
|
2018-08-20 |
2022-07-26 |
Massachusetts Institute Of Technology |
Robotic manipulation of objects using external contacts
|
|
WO2020055941A1
(en)
|
2018-09-13 |
2020-03-19 |
Excision Biotherapeutics, Inc. |
Compositions and methods for excision with single grna
|
|
CN110904045A
(zh)
|
2018-09-17 |
2020-03-24 |
中国科学院动物研究所 |
经修饰的t细胞、其制备方法及用途
|
|
JP2022512703A
(ja)
|
2018-10-16 |
2022-02-07 |
インテリア セラピューティクス，インコーポレイテッド |
免疫療法のための組成物および方法
|
|
UY38427A
(es)
*
|
2018-10-26 |
2020-05-29 |
Novartis Ag |
Métodos y composiciones para terapia con células oculares
|
|
US20220133790A1
(en)
|
2019-01-16 |
2022-05-05 |
Beam Therapeutics Inc. |
Modified immune cells having enhanced anti-neoplasia activity and immunosuppression resistance
|
|
WO2020168122A1
(en)
|
2019-02-13 |
2020-08-20 |
Beam Therapeutics Inc. |
Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
|
|
US20220298494A1
(en)
|
2019-02-14 |
2022-09-22 |
Metagenomi Ip Technologies, Llc |
Enzymes with ruvc domains
|
|
US20220220460A1
(en)
|
2019-02-14 |
2022-07-14 |
Metagenomi Ip Technologies, Llc |
Enzymes with ruvc domains
|
|
US10913941B2
(en)
|
2019-02-14 |
2021-02-09 |
Metagenomi Ip Technologies, Llc |
Enzymes with RuvC domains
|
|
AU2020223370B2
(en)
|
2019-02-14 |
2023-04-20 |
Metagenomi Therapeutics, Inc. |
Enzymes with RuvC domains
|
|
EP3924467A1
(en)
*
|
2019-02-15 |
2021-12-22 |
Editas Medicine, Inc. |
Modified natural killer (nk) cells for immunotherapy
|
|
JP2020154564A
(ja)
|
2019-03-19 |
2020-09-24 |
富士通株式会社 |
学習方法、学習プログラムおよび学習装置
|
|
US20220235340A1
(en)
|
2019-05-20 |
2022-07-28 |
The Broad Institute, Inc. |
Novel crispr-cas systems and uses thereof
|
|
WO2021097118A1
(en)
|
2019-11-12 |
2021-05-20 |
The Broad Institute, Inc. |
Small type ii cas proteins and methods of use thereof
|
|
EP4127155A1
(en)
|
2020-03-31 |
2023-02-08 |
Metagenomi, Inc. |
Class ii, type ii crispr systems
|
|
GB2608292B
(en)
|
2020-03-31 |
2024-02-14 |
Metagenomi Inc |
Class II, type II CRISPR systems
|
|
KR20230021657A
(ko)
|
2020-05-08 |
2023-02-14 |
메타지노미, 인크. |
Ruvc 도메인을 포함하는 효소
|
|
EP4165177A4
(en)
|
2020-05-08 |
2024-08-28 |
Metagenomi, Inc. |
ENZYMES WITH RUVC DOMAINS
|
|
CA3192224A1
(en)
|
2020-09-11 |
2022-03-17 |
Jyun-Liang LIN |
Base editing enzymes
|
|
CN112126661B
(zh)
|
2020-09-30 |
2022-07-22 |
上海中医药大学 |
一种高效敲除nk细胞中tigit基因的方法
|
|
AU2021364399A1
(en)
|
2020-10-23 |
2023-05-11 |
Massachusetts Institute Of Technology |
Reprogrammable iscb nucleases and uses thereof
|
|
WO2022132765A1
(en)
*
|
2020-12-14 |
2022-06-23 |
Emendobio Inc. |
Biallelic knockout of b2m
|
|
BR112023014719A2
(pt)
*
|
2021-01-22 |
2023-12-05 |
Metagenomi Inc |
Novas nucleases quiméricas e manipuladas
|
|
BR112023018948A2
(pt)
|
2021-03-19 |
2023-10-17 |
Metagenomi Inc |
Edição multiplex com enzimas cas
|
|
WO2022232638A2
(en)
|
2021-04-30 |
2022-11-03 |
Metagenomi, Inc. |
Enzymes with ruvc domains
|
|
CA3225082A1
(en)
|
2021-08-27 |
2023-03-02 |
Brian C. Thomas |
Enzymes with ruvc domains
|
|
MX2024006257A
(es)
|
2021-11-24 |
2024-07-29 |
Metagenomi Inc |
Sistemas de endonucleasas.
|
|
WO2023097262A1
(en)
|
2021-11-24 |
2023-06-01 |
Metagenomi, Inc. |
Endonuclease systems
|
|
WO2023178115A2
(en)
*
|
2022-03-14 |
2023-09-21 |
Metagenomi, Inc. |
Engineered and chimeric nucleases
|